schliessen

Filtern

 

Bibliotheken

Small molecule proprotein convertase inhibitors for inhibition of embryo implantation

Uterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidi... Full description

Journal Title: PLoS ONE 01 January 2013, Vol.8(12), p.e81380
Main Author: Huiting Ho
Other Authors: Harmeet Singh , Sophea Heng , Tracy L Nero , Sarah Paule , Michael W Parker , Alan T Johnson , Guan-Sheng Jiao , Guiying Nie
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0081380
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: doaj_soai_doaj_org_article_66cb501266e04aa08ff0b13a107f6651
title: Small molecule proprotein convertase inhibitors for inhibition of embryo implantation
format: Article
creator:
  • Huiting Ho
  • Harmeet Singh
  • Sophea Heng
  • Tracy L Nero
  • Sarah Paule
  • Michael W Parker
  • Alan T Johnson
  • Guan-Sheng Jiao
  • Guiying Nie
subjects:
  • Sciences (General)
ispartof: PLoS ONE, 01 January 2013, Vol.8(12), p.e81380
description: Uterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidic small molecule compounds that were previously reported as potent inhibitors of furin, another PC member. We examined (i) the potency of these compounds in inhibiting PC6 activity in vitro; (ii) their binding modes in the PC6 active site in silico; (iii) their efficacy in inhibiting PC6-dependent cellular processes essential for embryo implantation using human cell-based models. All five compounds showed potent inhibition of PC6 activity in vitro, and in silico docking demonstrated that these inhibitors could adopt a similar binding mode in the PC6 active site. However, when these compounds were tested for their inhibition of decidualization of primary human endometrial stromal cells, a PC6-dependent cellular process critical for embryo implantation, only one (compound 1o) showed potent inhibition. The lack of activity in the cell-based assay may reflect the inability of the compounds to penetrate the cell membrane. Because compound's lipophilicity is linked to cell penetration, a measurement of lipophilicity (logP) was calculated for each compound. Compound 1o is unique as it appears the most lipophilic among the five compounds. Compound 1o also inhibited another crucial PC6-dependent process, the attachment of human trophoblast spheroids to endometrial epithelial cells (a model for human embryo attachment). We thus identified compound 1o as a potent small molecule PC6 inhibitor with pharmaceutical potential to inhibit embryo implantation. Our findings also highlight that human cell-based functional models are vital to complement the biochemical and in silico analyses in the selection of promising drug candidates. Further investigations for compound 1o are warranted in animal models to test its utility as an implantation-inhibiting contraceptive drug.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0081380
fulltext: fulltext_linktorsrc
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID579324524
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidoai_doaj_org_article_66cb501266e04aa08ff0b13a107f6651
sourceiddoaj_s
recordidTN_doaj_soai_doaj_org_article_66cb501266e04aa08ff0b13a107f6651
sourcesystemOther
dbidDOA
pqid1467062597
galeid478431829
display
typearticle
titleSmall molecule proprotein convertase inhibitors for inhibition of embryo implantation
creatorHuiting Ho ; Harmeet Singh ; Sophea Heng ; Tracy L Nero ; Sarah Paule ; Michael W Parker ; Alan T Johnson ; Guan-Sheng Jiao ; Guiying Nie
ispartofPLoS ONE, 01 January 2013, Vol.8(12), p.e81380
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0081380
subjectSciences (General)
descriptionUterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidic small molecule compounds that were previously reported as potent inhibitors of furin, another PC member. We examined (i) the potency of these compounds in inhibiting PC6 activity in vitro; (ii) their binding modes in the PC6 active site in silico; (iii) their efficacy in inhibiting PC6-dependent cellular processes essential for embryo implantation using human cell-based models. All five compounds showed potent inhibition of PC6 activity in vitro, and in silico docking demonstrated that these inhibitors could adopt a similar binding mode in the PC6 active site. However, when these compounds were tested for their inhibition of decidualization of primary human endometrial stromal cells, a PC6-dependent cellular process critical for embryo implantation, only one (compound 1o) showed potent inhibition. The lack of activity in the cell-based assay may reflect the inability of the compounds to penetrate the cell membrane. Because compound's lipophilicity is linked to cell penetration, a measurement of lipophilicity (logP) was calculated for each compound. Compound 1o is unique as it appears the most lipophilic among the five compounds. Compound 1o also inhibited another crucial PC6-dependent process, the attachment of human trophoblast spheroids to endometrial epithelial cells (a model for human embryo attachment). We thus identified compound 1o as a potent small molecule PC6 inhibitor with pharmaceutical potential to inhibit embryo implantation. Our findings also highlight that human cell-based functional models are vital to complement the biochemical and in silico analyses in the selection of promising drug candidates. Further investigations for compound 1o are warranted in animal models to test its utility as an implantation-inhibiting contraceptive drug.
languageeng
oafree_for_read
source
version9
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://doaj.org/article/66cb501266e04aa08ff0b13a107f6651$$EView_full_text_in_DOAJ
search
creatorcontrib
0Huiting Ho
1Harmeet Singh
2Sophea Heng
3Tracy L Nero
4Sarah Paule
5Michael W Parker
6Alan T Johnson
7Guan-Sheng Jiao
8Guiying Nie
titleSmall molecule proprotein convertase inhibitors for inhibition of embryo implantation
description

Uterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidic small molecule compounds that were previously reported as potent inhibitors of furin, another PC member. We examined (i) the potency of these compounds in inhibiting PC6 activity in vitro; (ii) their binding modes in the PC6 active site in silico; (iii) their efficacy in inhibiting PC6-dependent cellular processes essential for embryo implantation using human cell-based models. All five compounds showed potent inhibition of PC6 activity in vitro, and in silico docking demonstrated that these inhibitors could adopt a similar binding mode in the PC6 active site. However, when these compounds were tested for their inhibition of decidualization of primary human endometrial stromal cells, a PC6-dependent cellular process critical for embryo implantation, only one (compound 1o) showed potent inhibition. The lack of activity in the cell-based assay may reflect the inability of the compounds to penetrate the cell membrane. Because compound's lipophilicity is linked to cell penetration, a measurement of lipophilicity (logP) was calculated for each compound. Compound 1o is unique as it appears the most lipophilic among the five compounds. Compound 1o also inhibited another crucial PC6-dependent process, the attachment of human trophoblast spheroids to endometrial epithelial cells (a model for human embryo attachment). We thus identified compound 1o as a potent small molecule PC6 inhibitor with pharmaceutical potential to inhibit embryo implantation. Our findings also highlight that human cell-based functional models are vital to complement the biochemical and in silico analyses in the selection of promising drug candidates. Further investigations for compound 1o are warranted in animal models to test its utility as an implantation-inhibiting contraceptive drug.

subjectSciences (General)
general
0English
1Public Library of Science (PLoS)
210.1371/journal.pone.0081380
3Directory of Open Access Journals (DOAJ)
sourceiddoaj_s
recordiddoaj_soai_doaj_org_article_66cb501266e04aa08ff0b13a107f6651
issn
01932-6203
119326203
rsrctypearticle
creationdate2013
addtitlePLoS ONE
searchscope
0doaj_full
1doaj1
scope
0doaj_full
1doaj1
lsr45$$EView_full_text_in_DOAJ
tmp01Directory of Open Access Journals (DOAJ)
tmp02DOA
startdate20130101
enddate20130101
lsr40PLoS ONE, 01 January 2013, Vol.8 (12), p.e81380
doi10.1371/journal.pone.0081380
citationpf e81380 vol 8 issue 12
lsr30VSR-Enriched:[galeid, pages, pqid]
sort
titleSmall molecule proprotein convertase inhibitors for inhibition of embryo implantation
authorHuiting Ho ; Harmeet Singh ; Sophea Heng ; Tracy L Nero ; Sarah Paule ; Michael W Parker ; Alan T Johnson ; Guan-Sheng Jiao ; Guiying Nie
creationdate20130101
lso0120130101
facets
frbrgroupid7056295402963689295
frbrtype5
newrecords20190714
languageeng
topicSciences (General)
collectionDirectory of Open Access Journals (DOAJ)
prefilterarticles
rsrctypearticles
creatorcontrib
0Huiting Ho
1Harmeet Singh
2Sophea Heng
3Tracy L Nero
4Sarah Paule
5Michael W Parker
6Alan T Johnson
7Guan-Sheng Jiao
8Guiying Nie
jtitlePLoS ONE
creationdate2013
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
au
0Huiting Ho
1Harmeet Singh
2Sophea Heng
3Tracy L Nero
4Sarah Paule
5Michael W Parker
6Alan T Johnson
7Guan-Sheng Jiao
8Guiying Nie
atitleSmall molecule proprotein convertase inhibitors for inhibition of embryo implantation
jtitlePLoS ONE
risdate20130101
volume8
issue12
spagee81380
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstract

Uterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidic small molecule compounds that were previously reported as potent inhibitors of furin, another PC member. We examined (i) the potency of these compounds in inhibiting PC6 activity in vitro; (ii) their binding modes in the PC6 active site in silico; (iii) their efficacy in inhibiting PC6-dependent cellular processes essential for embryo implantation using human cell-based models. All five compounds showed potent inhibition of PC6 activity in vitro, and in silico docking demonstrated that these inhibitors could adopt a similar binding mode in the PC6 active site. However, when these compounds were tested for their inhibition of decidualization of primary human endometrial stromal cells, a PC6-dependent cellular process critical for embryo implantation, only one (compound 1o) showed potent inhibition. The lack of activity in the cell-based assay may reflect the inability of the compounds to penetrate the cell membrane. Because compound's lipophilicity is linked to cell penetration, a measurement of lipophilicity (logP) was calculated for each compound. Compound 1o is unique as it appears the most lipophilic among the five compounds. Compound 1o also inhibited another crucial PC6-dependent process, the attachment of human trophoblast spheroids to endometrial epithelial cells (a model for human embryo attachment). We thus identified compound 1o as a potent small molecule PC6 inhibitor with pharmaceutical potential to inhibit embryo implantation. Our findings also highlight that human cell-based functional models are vital to complement the biochemical and in silico analyses in the selection of promising drug candidates. Further investigations for compound 1o are warranted in animal models to test its utility as an implantation-inhibiting contraceptive drug.

pubPublic Library of Science (PLoS)
doi10.1371/journal.pone.0081380
urlhttps://doaj.org/article/66cb501266e04aa08ff0b13a107f6651
lad01PLoS ONE
oafree_for_read
pagese81380
date2013-01-01